HHS Panel Backs Off MRNA COVID Shot Restrictions

0:00On March 11, a key U.S. federal vaccine advisory panel has backed away from efforts to limit recommendations for mRNA COVID shots. Advisors under health and human services, Secretary Robert F. Kennedy Jr. had been considering a full stop on those vaccines, but sources say that. Pushes now off the table. Last September, the panel shifted away from blanket approvals for COVID vaccines, opting instead for shared decision-making between patients and doctors on the CDC schedule. HHS officials confirm the group has not revisited then-move from September 2025. Kennedy, a vocal vaccine critic, has influenced changes like winding down mRNA research at a key government lab last August. The advisors are set to meet next week to update guidance on vaccines for Americans. Kennedy has questioned the shot's effectiveness against respiratory illnesses, even as evidence supports their role. These mRNA vaccines from companies like Pfizer, BioNTech, and Moderna teach cells to produce

1:05a harmless virus protein, building immunity without using live virus. With the meeting ahead, watch for how recommendations evolve.